Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2014

Study Completion Date

June 30, 2014

Conditions
Ulcerative Colitis
Interventions
DRUG

methotrexate

25 mg per week IM or SC during 24 weeks

DRUG

placebo

one intramuscular injection per week

Trial Locations (22)

1090

University Hospital of Vienna, Vienna

1200

ULB - Cliniques Saint Luc, Brussels

2333

LUMC, Leiden

20089

Istituto Clinico Humanitas, Rozzano , Milano

25000

Centre Hospitalier Universitaire de Besançon, Besançon

31403

CHU Toulouse - Hôpital Rangueil, Toulouse

33604

CHU Bordeaux - Hôpital Haut L'Eveque, Pessac

42270

CHU St Etienne - Hôpital NOrd, Saint-Priest

44000

CHU Nantes - Hôpital Hôtel Dieu, Nantes

52621

Sheba Medical Center, Tel Aviv

59037

CHRU Lille - Hôpital Huriez, Lille

63000

CHU Clermont-Ferrand - Hôpital Hotel Dieu, Clermont-Ferrand

71013

Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo

75010

APHP - Hôpital Saint Louis, Paris

75012

APHP - Hôpital Saint Antoine, Paris

75014

APHP - Hôpital Cochin, Paris

76000

CHU Rouen - Hôpital Charles Nicolle, Rouen

84000

CHU Amiens - Hôpital Nord, Amiens

CH Avignon, Avignon

92110

APHP - Hôpital Beaujon, Clichy

94270

APHP - Hôpital Bicêtre, Le Kremlin-Bicêtre

06202

CHU Nice - Hôpital de l'Archet 2, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT00498589 - Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis | Biotech Hunter | Biotech Hunter